Delivery Order SPE2DE24D0021-SPE2D625F3ANY
- Not listed
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1.65K to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by October 22, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle structure, with no small...
- The U.S. Defense Department's Medical Supply Chain awarded a fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on July 22, 2025, for the procurement of SOFIA 2 FLU + SARS 25S diagnostic testing supplies. The delivery order, valued at $4,423.36, represents a child contract with an ultimate completion date of September 17, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. This award was made through open competition...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- Fisher Scientific Company L.L.C. was awarded a $3,300 fixed-price delivery order by the Medical Supply Chain division of the Department of Defense on August 20, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. The contract represents an individual delivery order issued under a larger acquisition vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of October 17, 2025. This award was made through open competition with no...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $2,764.60 by the Defense Medical Supply Chain for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The delivery order, issued on August 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 6, 2025. The work will be performed in Pittsburgh, Pennsylvania. This award represents a child...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order to Fisher Scientific Company L.L.C. on September 4, 2025, for SOFIA Flu AB Test Kits (25 tests per pack) with a ceiling value of $1,846.27. This fixed-price delivery order with economic price adjustment pricing carries an ultimate completion date of September 11, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded through open competition with no set-aside designation,...
- The U.S. government's Defense agency, specifically the Medical Supply Chain, awarded a $2,750.00 fixed-price delivery order contract to Fisher Scientific Company L.L.C. (doing business as Fisher Scientific) on October 25, 2024. The contract, which does not have a set-aside designation, is for the delivery of SOFIA 2 FLU + SARS Antigen Fluorescent I test kits and is set to be completed by December 24, 2024. Fisher Scientific is a major supplier of scientific products, equipment, and services to...
- Fisher Scientific Company L.L.C. was awarded a $4,400 fixed-price delivery order with economic price adjustment authority for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies on September 4, 2025. The contract, which carries no set-aside designation, is a child award under a larger vehicle and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of October 31, 2025. The funding agency is the Department of Defense Medical...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on August 14, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies with a ceiling value of $4,400. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by October 10, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300.00 on August 18, 2025, for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 15, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract is funded through the Medical Supply Chain, a defense-oriented federal agency, and is structured as a child contract under a...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3ANYDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,200 to Fisher Scientific Company L.L.C. on September 10, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. The contract, which is not set-aside and carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 6, 2025, with performance to be completed in Pittsburgh, Pennsylvania. Fisher Scientific, a major supplier of laboratory and medical equipment to federal agencies, will fulfill this requirement as a child contract under a larger vehicle arrangement. This delivery order supports the Defense Department's medical supply chain operations, leveraging Fisher Scientific's extensive capabilities in providing specialized diagnostic and testing solutions. As a registered federal vendor since 2001, Fisher Scientific has demonstrated consistent ability to compete in open federal procurement and maintain critical supply relationships across defense and civilian agencies, including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration. The relatively modest contract value reflects a focused procurement for specialized antigen testing materials to support current operational needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/10/25 |